Table 2.
Comparison of symptom scores under different gastric dilatation volumes between the two groups.
| Observed indexes | Control group (n = 36) | Study group (n = 37) | ||
|---|---|---|---|---|
| Before treatment | After treatment | Before treatment | After treatment | |
| Epigastric pain | ||||
| 200 ml | 0.94 ± 0.23 | 0.72 ± 0.45 | 0.95 ± 0.23 | 0.05 ± 0.23∗,# | 
| 300 ml | 1.86 ± 0.76 | 1.06 ± 0.47∗ | 1.62 ± 0.72 | 0.62 ± 0.49∗,# | 
| 400 ml | 2.42 ± 0.65 | 1.47 ± 0.65∗ | 2.27 ± 0.80 | 1.00 ± 0.08∗,# | 
| Fullness | ||||
| 200 ml | 1.08 ± 0.28 | 0.97 ± 0.17 | 1.14 ± 0.35 | 0.30 ± 0.46∗,# | 
| 300 ml | 1.97 ± 0.70 | 1.33 ± 0.79∗ | 1.65 ± 0.86 | 0.862 ± 0.48∗,# | 
| 400 ml | 2.39 ± 0.69 | 1.89 ± 0.68∗ | 2.49 ± 0.61 | 1.32 ± 0.67∗,# | 
| Nausea or vomiting | ||||
| 200 ml | 1.00 ± 0.24 | 0.67 ± 0.48 | 0.97 ± 0.29 | 0.11 ± 0.31∗,# | 
| 300 ml | 1.78 ± 0.68 | 1.14 ± 0.59∗ | 1.92 ± 0.80 | 0.65 ± 0.54∗,# | 
| 400 ml | 2.19 ± 0.82 | 1.44 ± 0.69∗ | 1.95 ± 0.81 | 0.97 ± 0.50∗,# | 
Note: ∗ meant P < 0.05 vs. before treatment; # meant P < 0.05 vs. after treatment in control group.